Phia Group

List Prices in TV Ads: Will This Help?

On May 31, 2019
Big changes are coming to drug advertisements on TV. Learn how price transparency will affect the healthcare industry & its manufacturers.

Denial & Appeal Case Study: A Deep Dive (Literally)

On May 28, 2019
When you analyze a Plan Document, how can you know which words to rely on? Read this denial & appeal case study to learn how to better approach the situation.

To Pay, or Not to Pay … The Guide to Handling Claims, Denials, and Appeals

On May 23, 2019
Join The Phia Group’s legal team as they discuss the good, bad, and ugly truths about the claims process, and how to safely navigate the various TPA and health plan duties associated with it.

IP Law vs. Drug Prices

On May 20, 2019
Are you being overcharged by your healthcare plan for your own prescriptions? Learn more about IP Law and Drug prices. Call us for a claim negotiation!

CMS Finalizes Drug Price Transparency Rule

On May 17, 2019
New rules in drug pricing transparency will require prescription manufacturers to provide wholesale prices to consumers in television ads. Learn its impact!

Faces of Phia: Episode 12 – Pat 'the Man' Santos Has Got it In the Bag

On May 7, 2019
In this groundbreaking episode, Pat 'the Man' Santos – our silent producer, is silent no longer! Listen (if you dare) as he grabs the mic and goes toe to toe with our hosts. Learn of his daring escape from mediocrity, journey of self-awareness, and eventual role with The Phia Group. This is the one you’ve been waiting for. Don’t miss it.

Big Pharma Executives Testify Before Congress (Again)

On May 3, 2019
Executives from major drug companies testified before the Senate Finance Committee. Read about their proposed solutions for price increases & transparency.